Close X
Attorney Spotlight

What emerging trend in shareholder litigation does Britt Latham find most interesting in his practice today?    Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Attorney Spotlight: Britt Latham

September 5, 2018
Britt Latham spotlight

1. Tell us about your practice.

As co-chair of our Securities and Shareholder Litigation Practice Group, my practice primarily focuses on defending and counseling public companies and their directors and officers in securities fraud class actions, actions related to or arising out of corporate transactions and in investigations initiated by the Securities and Exchange Commission. 

2. What is an interesting trend happening right now related to your field of practice?

Following a 2016 decision by the Delaware Court of Chancery to no longer approve (absent certain conditions) "disclosure only" settlements in shareholder class actions that are routinely filed following the announcement of a public company merger or acquisition, it has been interesting to see whether other states will follow Delaware's lead and whether and where plaintiffs will continue to file these actions. As the plaintiffs' bar gets more creative in bringing these actions and identifying other opportunities to pursue securities and shareholder litigation, it has been fun identifying the best ways to defend or try to avoid these claims. 

3. Why did you choose to pursue a career in the legal field? 

My father always told me that he wanted to go to law school but didn't have the grades. As a result, he put the idea in my head at an early age. As I started to learn more about legal analysis and advocacy, I was hooked. Not only was it interesting and exciting to me but it was also a great fit for my strengths and skills.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.